Overview
Myeloid leukemia is a group of cancers of the blood and bone marrow that arise from the myeloid lineage of blood-forming cells, in which abnormal cells proliferate and crowd out normal blood production. The resulting deficiency of healthy red cells, white cells, and platelets leads to anemia, susceptibility to infection, and bleeding tendencies. The two principal forms are acute myeloid leukemia (AML), which progresses rapidly with the accumulation of immature blast cells, and chronic myeloid leukemia (CML), which typically advances more slowly and is characterized in most cases by the Philadelphia chromosome and the resulting BCR-ABL fusion gene. Diagnosis relies on blood and bone marrow examination, cytogenetic and molecular testing, and immunophenotyping, while treatment may include chemotherapy, targeted agents such as tyrosine kinase inhibitors, and hematopoietic stem cell transplantation. Early and accurate diagnosis, along with adherence to therapy, strongly influences outcomes. Research grouped under this topic reflects several of these areas, including transformation of myelofibrosis into Philadelphia-positive chronic myeloid leukemia, cutaneous lesions in acute myeloid leukemia with neutropenia, the role of neuropilin-1 in leukemogenesis, medication adherence in chronic myeloid leukemia, chromosomal findings such as the Philadelphia chromosome, complications of stem cell transplantation, and molecular biomarker and proteomic-genomic approaches relevant to cancer diagnosis and personalized medicine.
Research published in this journal
12 peer-reviewed articles, ranked by relevance. Each links to its DOI.
A Solitary Necrotic Lesion in A Man with Acute Myeloid Leukemia and neutropenia
Study of Neuropilin-1/Cd304 Expression in Leukemogenesis
Drivers and Barriers to Medication Adherence in Patients with Chronic Myeloid Leukaemia: A Qualitative Study
Complementary and Alternative Treatments for Cancer Prevention and Cure (Part 1)
Immune Thrombocytopenia after Allogeneic Stem Cell Transplantation: Case Report and Brief Overview of Treatment Strategies
A Patient with Monoclonal Gammopathy of Undetermined Significance and Detected Philadelphia Chromosome
Epigenetics and Nutrition
Molecular Biomarkers: A Brief Review
Proteomic and Genomic Techniques in Medical Research: Applications in Cancer, Diagnostics, and Personalized Medicine
Splenectomy Reports
Cell Therapy as an Alternative approach for COVID-19 Infection Consequences: A Non-Systematic Review
How this research is being cited
The 12 articles above have been cited 17 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2023 · European Journal of Cancer Care
-
2023 · European Journal of Oncology Nursing
-
Jaekwon Seok et al. · 2023 · Journal of Translational Medicine
-
2023 · European Journal of Oncology Nursing
-
2023 · European Journal of Cancer Care
-
Iman Ehsan et al. · 2022 · Journal of Drug Delivery Science and Technology
-
2022 · Hematology/Oncology and Stem Cell Therapy
-
2020 · Hematology/Oncology and Stem Cell Therapy
A sample of recent works citing this journal's research on Myeloid Leukemia, linking to each citing work.